Effects of nintedanib on the microvascular architecture in a lung fibrosis model

Abstract

Nintedanib, a tyrosine kinase inhibitor approved for the treatment of idiopathic pulmonary fibrosis, has anti-fibrotic, anti-inflammatory, and anti-angiogenic activity. We explored the impact of nintedanib on microvascular architecture in a pulmonary fibrosis model. Lung fibrosis was induced in C57Bl/6 mice by intratracheal bleomycin (0.5 mg/kg). Nintedanib was started after the onset of lung pathology (50 mg/kg twice daily, orally). Micro-computed tomography was performed via volumetric assessment. Static lung compliance and forced vital capacity were determined by invasive measurements. Mice were subjected to bronchoalveolar lavage and histologic analyses, or perfused with a casting resin. Microvascular corrosion casts were imaged by scanning electron microscopy and synchrotron radiation tomographic microscopy, and quantified morphometrically. Bleomycin administration resulted in a significant increase in higher-density areas in the lungs detected by micro-computed tomography, which was significantly attenuated by nintedanib. Nintedanib significantly reduced lung fibrosis and vascular proliferation, normalized the distorted microvascular architecture, and was associated with a trend toward improvement in lung function and inflammation. Nintedanib resulted in a prominent improvement in pulmonary microvascular architecture, which outperformed the effect of nintedanib on lung function and inflammation. These findings uncover a potential new mode of action of nintedanib that may contribute to its efficacy in idiopathic pulmonary fibrosis.

Consensus guidelines for the use and interpretation of angiogenesis assays

“…Interestingly, microfluidics allows generating chemical gradients and enables the study of EC chemotaxis in 3D geometries. These systems also contain networks of micron-scale fluid-filled channels that are similar in size and architecture to microvessels in vivo [205, 206] to faithfully reproduce certain microvascular phenomena in vitro. Consequently, the application of microfluidics for studying angiogenesis has emerged as a major research thrust at the interface of microsystems engineering and biomedicine.…”

Nintedanib in Idiopathic Pulmonary Fibrosis: Practical Management Recommendations for Potential Adverse Events

“…It has since been shown to have anti-fibrotic, anti-inflammatory, and anti-angiogenic activity [10-12]. The efficacy and safety of nintedanib for the indication IPF were evaluated across 3 clinical trials, the phase II TOMORROW trial, and the phase III INPULSIS trials (INPULSIS-1 and INPULSIS-2) [13, 14].…”

NR4A1 Promotes Diabetic Nephropathy by Activating Mff-Mediated Mitochondrial Fission and Suppressing Parkin-Mediated Mitophagy

“…In addition, uncontrolled mitochondrial division produces a large amount of mitochondrial debris, leading to an inadequate distribution of mitochondrial DNA within the mitochondria [11]. The damage to the mitochondrial genome suppresses the copying and transcription of the mitochondrial respiratory complex, interrupting cellular ATP production [12]. Abnormal mitochondrial fission promotes the opening of the mitochondrial permeability transition pore (mPTP) and cytochrome-c (cyt-c) leakage from mitochondria into cytoplasm, finally activating mitochondria-dependent cellular apoptosis [13,14].…”